BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21047645)

  • 1. rs5848 polymorphism and serum progranulin level.
    Hsiung GY; Fok A; Feldman HH; Rademakers R; Mackenzie IR
    J Neurol Sci; 2011 Jan; 300(1-2):28-32. PubMed ID: 21047645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum progranulin is not associated with rs5848 polymorphism in Korean patients with neurodegenerative diseases.
    Jung NY; Kim HS; Kim ES; Jeon S; Lee MJ; Pak K; Lee JH; Lee YM; Lee K; Shin JH; Ko JK; Lee JM; Yoon JA; Hwang C; Choi KU; Huh GY; Kim YE; Kim EJ
    PLoS One; 2022; 17(1):e0261007. PubMed ID: 35085262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.
    Pickering-Brown SM; Rollinson S; Du Plessis D; Morrison KE; Varma A; Richardson AM; Neary D; Snowden JS; Mann DM
    Brain; 2008 Mar; 131(Pt 3):721-31. PubMed ID: 18192287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia.
    Rademakers R; Eriksen JL; Baker M; Robinson T; Ahmed Z; Lincoln SJ; Finch N; Rutherford NJ; Crook RJ; Josephs KA; Boeve BF; Knopman DS; Petersen RC; Parisi JE; Caselli RJ; Wszolek ZK; Uitti RJ; Feldman H; Hutton ML; Mackenzie IR; Graff-Radford NR; Dickson DW
    Hum Mol Genet; 2008 Dec; 17(23):3631-42. PubMed ID: 18723524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease.
    Fenoglio C; Galimberti D; Cortini F; Kauwe JS; Cruchaga C; Venturelli E; Villa C; Serpente M; Scalabrini D; Mayo K; Piccio LM; Clerici F; Albani D; Mariani C; Forloni G; Bresolin N; Goate AM; Scarpini E
    J Alzheimers Dis; 2009; 18(3):603-12. PubMed ID: 19625741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
    Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
    J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.
    Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
    J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly.
    Dickson DW; Baker M; Rademakers R
    Neurodegener Dis; 2010; 7(1-3):170-4. PubMed ID: 20197700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.
    Finch N; Baker M; Crook R; Swanson K; Kuntz K; Surtees R; Bisceglio G; Rovelet-Lecrux A; Boeve B; Petersen RC; Dickson DW; Younkin SG; Deramecourt V; Crook J; Graff-Radford NR; Rademakers R
    Brain; 2009 Mar; 132(Pt 3):583-91. PubMed ID: 19158106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association of PGRN 3'UTR rs5848 in frontotemporal lobar degeneration.
    Rollinson S; Rohrer JD; van der Zee J; Sleegers K; Mead S; Engelborghs S; Collinge J; De Deyn PP; Mann DM; Van Broeckhoven C; Pickering-Brown SM
    Neurobiol Aging; 2011 Apr; 32(4):754-5. PubMed ID: 19446372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.
    Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G
    J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGRN Is Associated with Late-Onset Alzheimer's Disease: a Case-Control Replication Study and Meta-analysis.
    Xu HM; Tan L; Wan Y; Tan MS; Zhang W; Zheng ZJ; Kong LL; Wang ZX; Jiang T; Tan L; Yu JT
    Mol Neurobiol; 2017 Mar; 54(2):1187-1195. PubMed ID: 26820675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progranulin polymorphism rs5848 is associated with increased risk of Alzheimer's disease.
    Sheng J; Su L; Xu Z; Chen G
    Gene; 2014 Jun; 542(2):141-5. PubMed ID: 24680777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.
    Morenas-Rodríguez E; Cervera-Carles L; Vilaplana E; Alcolea D; Carmona-Iragui M; Dols-Icardo O; Ribosa-Nogué R; Muñoz-Llahuna L; Sala I; Belén Sánchez-Saudinós M; Blesa R; Clarimón J; Fortea J; Lleó A
    J Alzheimers Dis; 2016; 50(2):539-46. PubMed ID: 26682689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Progranulin and Gaucher Disease.
    Jian J; Zhao S; Tian QY; Liu H; Zhao Y; Chen WC; Grunig G; Torres PA; Wang BC; Zeng B; Pastores G; Tang W; Sun Y; Grabowski GA; Kong MX; Wang G; Chen Y; Liang F; Overkleeft HS; Saunders-Pullman R; Chan GL; Liu CJ
    EBioMedicine; 2016 Sep; 11():127-137. PubMed ID: 27515686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progranulin protein levels are differently regulated in plasma and CSF.
    Nicholson AM; Finch NA; Thomas CS; Wojtas A; Rutherford NJ; Mielke MM; Roberts RO; Boeve BF; Knopman DS; Petersen RC; Rademakers R
    Neurology; 2014 May; 82(21):1871-8. PubMed ID: 24771538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.
    Rademakers R; Baker M; Gass J; Adamson J; Huey ED; Momeni P; Spina S; Coppola G; Karydas AM; Stewart H; Johnson N; Hsiung GY; Kelley B; Kuntz K; Steinbart E; Wood EM; Yu CE; Josephs K; Sorenson E; Womack KB; Weintraub S; Pickering-Brown SM; Schofield PR; Brooks WS; Van Deerlin VM; Snowden J; Clark CM; Kertesz A; Boylan K; Ghetti B; Neary D; Schellenberg GD; Beach TG; Mesulam M; Mann D; Grafman J; Mackenzie IR; Feldman H; Bird T; Petersen R; Knopman D; Boeve B; Geschwind DH; Miller B; Wszolek Z; Lippa C; Bigio EH; Dickson D; Graff-Radford N; Hutton M
    Lancet Neurol; 2007 Oct; 6(10):857-68. PubMed ID: 17826340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progranulin peripheral levels as a screening tool for the identification of subjects with progranulin mutations in a Portuguese cohort.
    Almeida MR; Baldeiras I; Ribeiro MH; Santiago B; Machado C; Massano J; Guimarães J; Resende Oliveira C; Santana I
    Neurodegener Dis; 2014; 13(4):214-23. PubMed ID: 24022032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced serum progranulin level might be associated with Parkinson's disease risk.
    Mateo I; González-Aramburu I; Pozueta A; Vázquez-Higuera JL; Rodríguez-Rodríguez E; Sánchez-Juan P; Calero M; Dobato JL; Infante J; Berciano J; Combarros O
    Eur J Neurol; 2013 Dec; 20(12):1571-3. PubMed ID: 23398167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. rs5848 variant of progranulin gene is a risk of Alzheimer's disease in the Taiwanese population.
    Lee MJ; Chen TF; Cheng TW; Chiu MJ
    Neurodegener Dis; 2011; 8(4):216-20. PubMed ID: 21212639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.